BD has committed more than 800 million needles and syringes to date in support of COVID-19 vaccination campaigns globally – with discussions underway to provide millions more devices. But what happens next? How do these orders get into the hands of the health care workers who will be using them to deliver a vaccine? Getting … Continued
A test to detect Covid-19 that can be done at the point of care and gives results in 15 minutes has been given the greenlight in Europe, according to its maker, Becton Dickinson. The test should be commercially available in Europe by the end of October, the diagnostics specialist said Wednesday, as it announced its … Continued
Gov. Larry Hogan said Thursday that Maryland would be the first in a 10-state compact to buy large batches of a new kind of rapid coronavirus test for use in nursing homes, prisons and possibly college dorms and other places prone to outbreaks. The purchase of 250,000 rapid antigen tests, at $30 a test, would be … Continued
As researchers move promising vaccine candidates into clinical trials, it is estimated that a safe and effective COVID-19 vaccine could be available as soon as early 2021. But the challenge isn’t just creating a vaccine. It’s also critically important to make sure health care workers are supplied with the right injection devices that will ultimately be … Continued
Becton, Dickinson and Company (BD) has formed a strategic partnership with the Biomedical Advanced Research and Development Authority (BARDA) to establish new manufacturing lines for injection devices, providing the US Government with priority access to huge volumes of syringes and needles to support its ongoing and future pandemic vaccination efforts.
The FDA granted an emergency authorization to a portable coronavirus antigen test developed by BD, similar to a rapid flu test, designed to allow hospitals, doctors’ offices, urgent care centers and retail pharmacies to examine a person showing symptoms in about 15 minutes. At the same time, the agency alerted healthcare providers of potential false-positive results … Continued
BD is donating $750,000 to COVID-19 response efforts in the U.S. and internationally, in addition to the $350,000 in cash and product the Company donated to COVID-19 relief efforts in China earlier this year, bringing the Company’s total COVID-19 response contributions to $1.1 million. The new funding is being deployed through six non-profit partners, to … Continued
At a time when health care systems around the globe are struggling to keep up with the influx of patients from the COVID-19 crisis, BD employees with clinical backgrounds are stepping up to help. One of these amazing individuals, Adam Wires, RN, CVAA(C), VA-BC and a clinical specialist with BD – Canada, recently volunteered to … Continued
BD and BioGX Inc, announced March 16 that the companies have submitted Emergency Use Authorization requests to the U.S. Food and Drug Administration (FDA) for new diagnostic tests that, if authorized, would increase the potential capacity to screen for COVID-19 (coronavirus) by thousands of tests per day. The tests would help fill an urgent need … Continued